Related by context. All words. (Click for frequent words.) 70 pharmacogenetic testing 67 predictive biomarkers 67 companion diagnostics 66 epigenetic therapies 66 VKORC1 66 pharmacogenetics 66 pharmacogenomic 64 PGx 64 biomarker 64 pharmacogenomics 63 UGT#A# 63 eTag assays 63 toxicogenomics 63 Corus CAD 63 theranostic 63 CellPort Technologies 63 cMET 63 molecular biomarkers 63 Pertuzumab 62 vitro ADME 62 biomarker identification 62 genomewide 62 KRAS mutation 62 Mammostrat 62 predictive toxicology 62 ParAllele 62 DNA methylation biomarkers 62 pharmacogenetic tests 62 toxicogenomic 62 genetic biomarkers 62 GeneSightRx 62 microRNA biomarkers 62 Oncotype DX colon cancer 61 PGxPredict tests 61 CB1 antagonists 61 CYP#C# [002] 61 EGFR TKIs 61 NPM1 61 genomic biomarkers 61 siRNA therapeutics 61 biomarkers 61 diagnostic prognostic 61 CYP# [001] 61 Symadex 61 SNP genotyping 61 ADME Tox 61 CCR5 inhibitor 61 molecular profiling 61 pharmacogenomic testing 61 EGFR mutation status 61 pharmacogenetic test 61 VeriStrat 61 anticancer therapies 61 GFT# 61 gefitinib Iressa 61 prognostic markers 61 pharmacodynamic properties 61 PITX2 61 metaglidasen 61 CINQUIL 61 Onconase 61 Fc gamma receptor 61 predictive biomarker 61 viral kinetics 61 biologic therapeutics 61 MassARRAY platform 60 antiangiogenic agents 60 enzastaurin 60 KIF6 60 ALK inhibitors 60 MDx tests 60 LungExpress Dx 60 nutrigenomic 60 Aviptadil 60 MammaPrint 60 TLR9 agonists 60 AttoSense 60 KRAS mutation status 60 rEEG 60 DsiRNA 60 Spiegelmer ® 60 vascular disrupting agents 60 molecular biomarker 60 PLAC test 60 ONCONASE R 60 tranilast 60 metabolite identification 60 systemic RNAi 60 LungExpress Dx TM 60 SGLT2 inhibitors 60 Vilazodone 60 Septin 9 60 Genaissance 60 DXL# 60 antiangiogenesis 60 therapeutic radiopharmaceuticals 60 HERmark 60 genotyping 60 AclarusDx ™ 60 biomarker validation 60 Anticalin ® 60 PGxPredict 60 Bicifadine 59 aleglitazar 59 vidofludimus 59 Locked Nucleic Acid LNA 59 biomarker discovery 59 MAGE A3 ASCI 59 COLD PCR 59 TLE3 59 alvespimycin 59 Bucindolol 59 investigational therapies 59 AZILECT ® 59 preclinically 59 Anticalins ® 59 CobaCyte 59 pertuzumab 59 warfarin dosing 59 Cytolin R 59 ENMD # 59 biochemical profiling 59 XmAb# 59 diagnostic biomarker 59 biomarker assays 59 Onalta 59 validate biomarkers 59 Roche AmpliChip 59 insulin sensitizing 59 pharmacoeconomic 59 genomic 59 anti CD# antibodies 59 R#/MEM 59 diagnostic assays 59 CCX# 59 K ras 59 K RAS 59 galectin 3 59 bortezomib Velcade 59 Epigenomics proprietary 59 PreGen Plus 59 non pharmacological interventions 59 ganetespib 59 Anavex #-# 59 OnDose 59 atacicept 59 Anticalins R 59 metabolomic profiling 59 HER3 59 biomarker discovery validation 59 oral salmon calcitonin 59 TRIST study 59 miRNA profiling 59 genes CYP#C# 59 Affymetrix microarray technology 59 A3 adenosine receptor 59 EP #R 59 biomarker assay 59 Vidaza azacitidine 59 MEK inhibitors 59 Cerashield 59 kinase inhibitors 59 GAP #B# 59 tubulin inhibitor 59 Ceflatonin 59 insulin analogues 59 genomic proteomic 59 EGS# 59 CBLC# 59 LentiVector 59 JAK inhibitors 59 OHR/AVR# 58 HERmark assay 58 PDE7 inhibitors 58 Azedra 58 therapeutic monoclonal antibody 58 HIF PH inhibitors 58 renin inhibitors 58 novel oral anticoagulant 58 GPR# agonists 58 comparative genomic hybridization 58 bevacizumab Avastin ® 58 metabolomics 58 CLORETAZINE TM VNP#M 58 histone deacetylase inhibitor 58 Curaxin 58 elotuzumab 58 bisulfite sequencing 58 HTS assay 58 proteomic 58 reslizumab 58 epigenomics 58 APTIMA HPV 58 obatoclax 58 Pyridorin 58 HER2 overexpression 58 Septin9 58 Nanobody ® 58 rxRNA 58 trastuzumab Herceptin 58 BioSeek 58 microRNA profiling 58 Pravastatin 58 OvaRex R 58 nonclinical studies 58 FTIs 58 endoglin 58 DNA methylation markers 58 throughput RNAi 58 ResponseDX Lung TM 58 clinical pharmacology studies 58 vivo potency 58 shRNA libraries 58 molecularly targeted 58 Pharmacogenetic 58 EGFR tyrosine kinase inhibitors 58 epigenetic therapeutics 58 insulin analogs 58 DNA methyltransferases 58 Dalbavancin 58 synthetic lethality 58 PDE# inhibitors 58 therapeutic monoclonal antibodies 58 Nexavar sorafenib 58 monoclonal antibody therapeutics 58 gamma secretase inhibitors 58 whole genome genotyping 58 eprotirome 58 PD2i ® 58 risk stratification 58 ADME properties 58 mTOR inhibitors 58 SERMs 58 NuroPro ® 58 antisense compounds 58 Octreolin 58 SARMs 58 Panzem 58 delafloxacin 58 Caris MPI 58 Haptoglobin 58 CYP#C# [001] 58 HCV protease inhibitors 58 TRO# 58 miRview mets 58 oral taxane 58 preclinical efficacy 58 Squalamine 58 ATL# [001] 58 genotypic 58 ZOLINZA 58 miRview ™ mets 58 antitumour 58 postapproval 58 OXi# 58 mGlu2 3 58 cardioprotective effects 58 custirsen 58 TRV# [001] 58 Epidermal Growth Factor Receptor 58 Stedivaze 58 antithrombotic 58 vitro assay 58 IMA# 58 sDNA 58 PCA3 assay 58 Tasimelteon 58 immunotherapeutic vaccine 58 OMP #M# 58 miRview meso 58 VeraTag assays 58 JAK3 57 PHX# 57 chemopreventive agents 57 gene expression profiling 57 Civacir 57 p# biomarker 57 Cardiotoxicity 57 Cloretazine ® 57 mechanistic insights 57 OnDose TM 57 co receptor tropism 57 NanoCrystal Technology 57 selective androgen receptor modulator 57 PARP inhibition 57 Staccato nicotine technology 57 olaparib 57 Posiphen 57 PDE4 inhibitor 57 Xanafide 57 YONDELIS 57 oncolytic 57 selective inhibition 57 Perforomist ™ Inhalation Solution 57 Gefitinib 57 Peptidomics 57 targeting PCSK9 57 siRNA mediated 57 DCCR 57 TPI ASM8 57 ALTTO 57 genomic profiling 57 personalized medicine 57 IAP inhibitors 57 ELACYT 57 LentiVector technology 57 AltheaDx 57 acadesine 57 bardoxolone methyl 57 therapeutic peptide 57 SIRT1 activation 57 YONDELIS R 57 PITX2 methylation 57 tiapamil 57 Zolinza 57 T#I [002] 57 multi analyte 57 pharmacogenomic tests 57 hERG 57 Rasagiline 57 HuLuc# 57 regorafenib 57 PrevOnco 57 biologic pathways 57 exome sequencing 57 pharmacotherapies 57 Pharmacogenomic 57 pharmacodynamic markers 57 anti angiogenic drugs 57 TLK# 57 cardiac repolarization 57 immunotherapeutic approaches 57 mTOR inhibition 57 vivo pharmacology 57 antiplatelet therapies 57 bardoxolone 57 Cloretazine R 57 Stapled Peptide 57 drug metabolizing enzymes 57 Modrenal 57 validating biomarkers 57 aurora kinase 57 Valdoxan 57 PROSTVAC TM 57 TKM ApoB 57 Syllego system 57 CA9 SCAN 57 lumiliximab 57 MDV# 57 histone deacetylase HDAC inhibitors 57 Oasmia 57 miRNA biomarkers 57 DNA methylation biomarker 57 PGxHealth 57 surrogate endpoint 57 receptor tyrosine kinase inhibitor 57 molecular determinants 57 Xinlay 57 antidiabetic 57 Isis antisense 57 immunotherapeutics 57 HeliScope Sequencer 57 eligen R technology 57 JAK inhibitor 57 ospemifene 57 agomelatine 57 GIPET 57 metabonomics 57 genotypic resistance 57 Affibody 57 neuroprotective properties 57 HyACT 57 SmartChip System 57 SCIB1 57 endophenotypes 57 Dyax phage display 57 MGd 57 ResponseDX Colon TM 57 Src inhibitors 57 novel VDA molecule 57 flavopiridol 57 Mipomersen 57 riociguat 57 HGS# 57 isoform selective 57 endothelin receptor antagonists 57 Fingertip Formulary 57 Dacogen injection 57 THR beta agonist 57 Targretin 57 Avise PG 57 SiMoA 57 bucindolol 57 Dapagliflozin 57 anti CD3 57 Scancell 57 Therapeutic Diagnostics 57 neratinib 57 epothilone 57 LEX System 57 HemeScan test 57 JAK2 57 miRview ™ squamous 57 vemurafenib 57 Annamycin 57 Fabry Disease 57 HuCAL antibodies 57 BRAF inhibitor 57 Temsirolimus 57 SNT MC# 57 small molecule activators 57 Alnylam RNAi 57 MammaPrint ® 57 NanoCrystal technology 57 gene loci 57 Amplimexon 57 SNP Genotyping 57 FLT3 57 torezolid phosphate 57 cediranib 57 Campath alemtuzumab 57 pharmacokinetic interactions 57 serum biomarkers 57 KRAS status 57 pharmacokinetic equivalence 57 metabolomics driven 57 inhibit EGFR 57 Phase IIb III 57 monoclonal antibody therapies 57 tumor subtypes 57 BioMAP 57 aCGH 57 Azacitidine 57 ALTROPANE 57 Oncotype DX breast cancer 57 molecularly targeted therapy 57 NS5A 57 chemopreventive agent 56 multigene expression test 56 BRAF inhibitors 56 AlloMap 56 novel peptide 56 KineMed 56 TLR agonists 56 tanespimycin 56 synthetic retinoid 56 NSCLC tumors 56 splice variants 56 Tyrima 56 ganaxolone 56 insulin sensitizers 56 Trandolapril 56 atrasentan 56 cytogenetic 56 Eli Lilly Cymbalta 56 proteasome inhibitor 56 CDK inhibitor 56 PKCi 56 PharmFilm ® 56 HQK 56 HSP# inhibitors 56 SILENOR 56 miRview TM mets 56 GLPG# 56 Elvitegravir 56 MetaCore TM 56 hedgehog pathway 56 PPAR gamma agonists 56 small molecule inhibitors 56 targeted radiotherapeutic 56 BCR ABL inhibitors 56 microRNA expression 56 miRNA therapeutics 56 NXL# 56 NuroPro R 56 Traficet EN 56 cytostatic 56 AlloMap testing 56 cancer immunotherapies 56 ALN PCS 56 chemoprevention 56 Ramoplanin 56 microtubule inhibitor 56 genomic alterations 56 potency selectivity 56 qNPA 56 Myocet 56 OvaRex MAb 56 Panzem R NCD 56 pharmacokinetics pharmacodynamics 56 erlotinib Tarceva 56 masitinib 56 PSN# [001] 56 trastuzumab DM1 T DM1 56 HMG CoA reductase inhibitors 56 novel anticancer 56 CDK inhibitors 56 CYT# potent vascular disrupting 56 antitumor effect 56 tumor hypoxia 56 Cellcept 56 Prodarsan ® 56 MedManage 56 Zevalin consolidation 56 PEGylated interferon 56 multitargeted 56 Oncotype 56 multigene 56 Genpathway 56 MAXY VII 56 Azedra TM 56 SUTENT ® 56 Ampakine 56 Immunotherapeutic 56 HSP# inhibitor 56 LY# [003] 56 GRNCM1 56 Vaxfectin TM 56 proteomic biomarkers 56 RIGScan CR 56 candidate TNFerade biologic 56 Olmesartan 56 intensive lipid lowering 56 pharmacodynamic PD 56 direct thrombin inhibitors 56 ARIKACE ™ 56 Aurora Kinase 56 Lp PLA 2 56 JAK2 inhibitors 56 RNAi therapeutic targeting 56 EOquin 56 antisense oligonucleotides 56 adrenergic regulation 56 triglyceride lowering 56 presymptomatic 56 MediGene focuses 56 VEGF inhibitors 56 human microdosing 56 molecular assays 56 PROCHYMAL 56 Carvedilol 56 kinase inhibition 56 AMPAKINE 56 VeraTag 56 SGLT 2 56 IRESSA 56 canakinumab 56 genomic biomarker 56 MammaPrint R 56 AIM HIGH 56 tipranavir 56 cellular immunotherapy 56 K ras mutations 56 oral PTH 56 anticancer therapeutics 56 genotype phenotype 56 Nanobodies ® 56 ASONEP 56 Pazopanib 56 SAR# [004] 56 BRACAnalysis 56 BREVAGen ™ 56 Xelox 56 optimal dosing 56 glucokinase activator 56 sipuleucel T 56 Aplidin 56 selective inhibitors 56 clevidipine 56 bioequivalency 56 Celator 56 zileuton CR 56 MGMT methylation 56 Aptivus 56 antithrombotics 56 Theranostics 56 AclarusDx 56 TGFBR1 * 6A 56 PARP inhibitors 56 Trofile 56 MicroRNA 56 AEG# 56 Nektar pulmonary 56 Psynova 56 Cytolin ® 56 prognostic indicators 56 noninvasive prenatal tests 56 anti angiogenic agents 56 INT# [002] 56 kidney urologic 56 GAMMAGARD 56 oral dnaJP1 56 Milnacipran 56 Targretin capsules 56 protein kinase inhibitors 56 p# inhibitors 56 OvaRex ® MAb 56 AeroLEF TM 56 HemeScan 56 LNP formulations 56 fosbretabulin 56 immunomodulation 56 Virulizin ® 56 OGeS 56 multiplexed assays 56 HCV antiviral 56 RISPERDAL ® 56 immune modulatory 56 LNA TM 56 Intervention Effectiveness 56 biostatistical analysis 56 genetic polymorphisms 56 ePRO solutions 56 ADAGIO study 56 Galectin 3 56 sorafenib tablets 56 liposomal formulation 56 diagnostic biomarkers 56 DiLA2 56 Oncotech 56 CTAP# Capsules 56 Cytochrome P# 56 RNA amplification 56 Tekturna HCT 56 FOLOTYN ® 56 Genetronics 56 decitabine 56 vorinostat 56 Capesaris 56 ReN# 56 STRIDE PD 56 DCVax R 56 Epitome Biosystems 56 LNPs 56 JAK2 inhibitor 56 glucagon receptor 56 microRNA 56 eIF4E 56 OncoVEX 56 kinase profiling 56 anti CD3 antibody 56 prostone 56 chemosensitivity 56 HIV integrase inhibitors 56 TBC# 56 Vectibix panitumumab 56 convenient dosing regimens 56 ChronVac C R 56 Kari Stefansson CEO 56 quantitative PCR qPCR 56 KRN# 56 NexACT ® 56 RNA antagonists 56 GLP toxicology 56 PD2i Analyzer 56 XmAb 56 CCR5 antagonist 56 Velcade bortezomib 56 quantitative gene expression 55 IgG1 antibodies 55 Adnectin 55 myeloproliferative disorders 55 CRLX# 55 Genedata 55 antihormonal 55 receptor subtypes 55 Novosom 55 microarray analysis 55 PORxin TM 55 OncotypeDX 55 multiplex immunoassay 55 faropenem 55 RGB # 55 GPx 55 Lumacan 55 bendamustine HCl 55 MDRNA proprietary 55 antitumor 55 renin inhibition 55 anti amnesic 55 mecamylamine 55 tumorigenicity 55 PDGF receptor 55 PEG SN# 55 pharmacokinetic PK study 55 Affibody ® molecules 55 Alexza Staccato 55 microarray 55 vivo validation 55 InterfeRx TM 55 tecarfarin 55 molecular diagnostic assays 55 prognostic biomarkers 55 GPCR targets 55 inhibit angiogenesis 55 novel immunomodulatory 55 HuMax EGFr 55 candidate CRLX# 55 trastuzumab Herceptin ® 55 nicotinic alpha 7 55 antihypertensive agents 55 Aurora kinase inhibitors 55 BrachySil TM 55 QTinno 55 TACI Ig 55 delta isoform 55 PXD# 55 atherosclerosis regression 55 novel peptides 55 #ME# 55 CDP# 55 Targeted Chemotherapy 55 TMEM#B 55 Tesmilifene 55 Diovan HCT 55 Oncotype DX ® 55 COX2 55 IAP inhibitor 55 inhibit viral replication 55 effector function 55 Allovectin 7 55 immatics 55 telomerase activation 55 GMX# 55 analyte specific 55 lipid lowering drugs 55 selective modulator 55 DPX Survivac 55 CYP#D# 55 XmAb ® 55 functional genomics 55 microarray gene expression 55 BioMAP ® 55 Estrogen Receptor 55 PLX# 55 ddRNAi 55 therapeutic mAbs 55 ADME 55 beta interferons 55 noninvasive prenatal 55 GSK3B 55 MabThera rituximab 55 Huntexil 55 celgosivir 55 anti fibrotic 55 Evoltra ® 55 KRAS mutations 55 uric acid lowering 55 platelet reactivity 55 chemical entities NCEs 55 pharmacodynamic parameters 55 AZILECT R 55 ticagrelor Brilinta 55 eIF 4E 55 histone deacetylases 55 galiximab 55 endothelin antagonists 55 miRview squamous 55 leflunomide 55 Captisol enabled 55 EC Cysteamine 55 FAMILION 55 CCR3 55 dasatinib Sprycel 55 gepirone ER 55 HIV protease inhibitors 55 fusion enhancers 55 otelixizumab 55 molecular markers 55 lapatinib Tykerb 55 uricase 55 methylation markers 55 CCR9 antagonist 55 breast cancer metastasis 55 Clonicel 55 TOCOSOL Camptothecin 55 BCR ABL inhibitor 55 Guanilib 55 Lupuzor 55 aerosolized AAT 55 neuropsychiatric diseases 55 daclizumab 55 OncoVEX GM CSF 55 glitazones 55 antidepressive 55 antithrombotic agents 55 miRNA assays 55 HemoGenix 55 histone deacetylase HDAC 55 Array CGH 55 prostanoid 55 AdnaGen 55 entinostat 55 Galenea 55 INTELENCE 55 NovaBay Aganocide compounds 55 pharmacologic intervention 55 breast cancer subtypes 55 dextofisopam 55 Spiegelmers R 55 mGluR2 NAM 55 molecular imaging radiopharmaceutical 55 single molecule sequencing 55 antiviral therapies 55 EGFR HER 55 PSMA ADC 55 metabolomic 55 ALN TTR# 55 PDE4 inhibitors 55 eniluracil 55 thymidylate synthase TS 55 APTIMA HPV assay 55 Exforge HCT 55 sigma receptors 55 ATTR CM 55 druggable targets 55 integrative genomics 55 NADiA 55 LHRH antagonist 55 Interferon beta 55 CYP#D# gene 55 PREVU x 55 nucleoside 55 BiTE 55 putative biomarkers 55 Urocidin TM 55 sorafenib Nexavar 55 siRNA therapeutic 55 Neuradiab 55 clinical 55 efficacy tolerability 55 Amigal 55 CD# antibody [001] 55 Oncotype DX Recurrence Score 55 CR# vcMMAE 55 radezolid 55 intranasal delivery 55 ATL# [002] 55 Syntonix 55 non nucleoside 55 selective estrogen receptor modulator 55 p# inhibitor 55 Icatibant 55 CTLA4 Ig 55 bendamustine 55 protein biomarker 55 multiplex assay 55 stratify patients 55 Li Fraumeni 55 optical biosensors 55 ColonSentry ™ 55 PANVAC VF 55 ALN TTR 55 Aurora kinase 55 APOE genotype 55 sirtuin modulators 55 Clofarabine 55 Reverse Cholesterol Transport 55 OvPlex 55 guideline concordant 55 NTDDS 55 inhibit metastasis 55 CLIA laboratory 55 AERx iDMS 55 NEUGENE 55 haplotype map 55 Cloretazine 55 therapeutic regimens 55 OVA1 55 HDAC inhibition 55 NB S# strontium malonate 55 elacytarabine 55 PROLARIS 55 poor metabolizers 55 orally inhaled migraine 55 protein biomarkers 55 dysbindin 55 HGS ETR2 55 QbD 55 NexACT 55 prognostic marker 55 p# activation 55 ELISpot 55 SurroMed 55 HGS ETR1 55 ixabepilone 55 Diabetes Risk Score 55 Exome 55 BioNumerik 55 candidate custirsen 55 Desmoteplase 55 DNA methylation patterns 55 mSEPT9 biomarker 55 REG1 55 FullTerm 55 metoprolol succinate 55 Genotypic 55 talabostat 55 oral antidiabetic 55 QTL mapping 55 immunoregulatory 55 BAY #-# 55 Removab 55 miR #a [002] 55 SRT# [003] 55 nCounter 55 thalidomide Thalomid 55 GKAs 55 Tolerx 55 nucleoside analogues 55 RhuDex 55 BiDil XR 55 sulphonylureas 55 Trofex 55 pomalidomide 55 miRNA expression 55 P2V TM 55 KIF6 carriers 55 chemogenomic 55 miR #b [002] 55 incretin 55 CEACAM1 55 cardiac channelopathies 55 multiparametric 55 antidiabetics 55 Lu AA# 55 GeneCards R 55 Angiocept 55 CellCentric 55 CYP#D# genotype 55 Epi proColon 55 LHRH antagonists 55 BACcel 55 pharmacological chaperone 55 proteasome inhibitors 55 Nanobody 55 PsychoGenics 55 DACH platinum 55 Dasatinib 54 forodesine 54 OncoVex 54 immunoregulation 54 chemopreventive 54 phase IIb clinical 54 biobetter 54 WaferGen SmartChip Real 54 echinocandin 54 ABCB1 54 Plicera 54 CRAC channel 54 Nalmefene 54 oral antiviral 54 Pulmotype 54 Perflubutane Polymer Microspheres 54 ZFP TF 54 reagent kits 54 anticancer treatments 54 IRX 2 54 antioxidant supplementation 54 adenosine A2A 54 Hexvix 54 HMGCR 54 Lp PLA2 54 Wellstat 54 autism susceptibility genes 54 resolvins 54 Anticalins 54 ToleroMune 54 Tasigna prolongs 54 ChIP chip 54 CupPrint 54 cardio metabolic 54 P#X# 54 Anticalin R 54 Altastaph 54 JAK3 inhibitor 54 metabolite profiling 54 illumigene C. difficile 54 Fludara ® 54 personalized immunotherapy 54 Urocidin 54 mertansine 54 optimal dosing regimens 54 SoftGenetics 54 gene expression assays 54 LDTs 54 bioinformatic approaches 54 RIP1 kinase 54 RhuDex ® 54 myelofibrosis polycythemia vera 54 VerifyNow P#Y# 54 BNC# 54 Sphingomab TM 54 transcriptional regulation 54 INCB# [001] 54 leukotriene receptor antagonists 54 GenPath 54 vicriviroc 54 AviaraDx